A recent headlines on the NBC News reads some cancer patients forgo life-saving medications because of high cost. this is especially true that because Medicare patient who don’t qualify for drug subsidies, one in three of them for go refilling their cancer care drugs because of the high cost.
According to the NBC news, monthly cost of Imbruvica, a cancer drug carries a wholesale price of $16,000 a month.
Low income (around $15,000 a year for an individual or about $30,000 a year for a married couple) medicare patients reportedly don’t qualify low-income subsidies.
Nishwant Swami, a researcher at the University of Massachusetts Medical, told NBC News “For cancer patients, the dilemma is especially dire because there are usually few lower-cost treatment alternatives.”